Table 1. Overview of the Synthesized Derivatives of Peptides E3 and K3 Used in This Studya.
spacer | DOPE anchor | LPEGd | cholesterol anchor | LPEGd |
---|---|---|---|---|
noneb | LP0E3/LP0K3 | 0.5 | CP0E3/CP0K3 | –0.5 |
PEG2c | LP2E3/LP2K3 | 1.6 | n.a. | n.a. |
PEG4 | LP4E3/LP4K3 | 2.3 | CP4E3/CP4K3 | 1.3 |
PEG8 | LP8E3/LP8K3 | 3.9 | CP8E3/CP8K3 | 2.9 |
PEG12 | LP12E3/LP12K3 | 5.4 | CP12E3/CP12K3 | 4.4 |
PEG16c | n.a. | n.a. | CP16E3/CP16K3 | 5.8 |
Peptide purities of >95% were confirmed using LC-MS for all constructs.
The peptide is connected to the anchor via a succinic diamide, with a length of 0.5 nm.
An LP2 spacer and a CP16 spacer were added to the PEG series to cover a significant range close to the maximum fusion efficiency.
LPEG is the distance between the N-terminus of the peptide and the surface of the membrane in nanometers. For DOPE anchors, this is the maximum theoretical chain length of the PEG spacer (nm), as estimated by AVOGADRO,43 and for cholesterol anchors, this is the maximum theoretical chain length, 1.0 nm,44 due to the intrinsic membrane insertion property of cholesterol in DOPC/DOPE membranes.